Last week, the United States Department of Justice issued an order moving FDA-approved marijuana products, as well as state-licensed medical marijuana products, to Schedule III of the Controlled Substances Act (CSA), implementing President Trump’s December 18, 2025, Executive Order.
| less than a minute read
Cannabis Rescheduling: What Does It Mean for Your Intellectual Property
Latest Insights
/Passle/684c7d72fa5dee4bb58c5944/SearchServiceImages/2026-09-10-15-24-13-283-6aa2cb9d181cfb8b954b9728.jpg)
/Passle/684c7d72fa5dee4bb58c5944/SearchServiceImages/2026-09-04-16-34-51-675-6a9af32b3a6dbbc3cdd79229.jpg)
/Passle/684c7d72fa5dee4bb58c5944/SearchServiceImages/2026-09-02-12-58-14-010-6a981d661321ba49cfe73cc9.jpg)
/Passle/684c7d72fa5dee4bb58c5944/SearchServiceImages/2026-09-01-16-51-34-445-6a970296f9386af8ea6ff12f.jpg)